Daniel Gustkey
Epilepsy · Austin, TXNPI 1962896241
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,433 of the $11,746 with a category attached, or 80.3%. 35 manufacturers reported payments, led by Livanova USA, Inc. at 24.4% of the total. Reporting peaked in 2024 at $6,911 and has fallen 53.9% since, to $3,189 in 2025.
Across 337 payments — averaging $34.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$3K
- Neuropace, Inc.$2K
- UCB, Inc.$1K
- Jazz Pharmaceuticals Inc.$1K
- SK Life Science, Inc.$1K
- Biocodex, Inc.$485
- plus $3K from 29 others
What the payments were for
- Travel & lodging$2,31220%
- Food & beverage$9,43380%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 66 | $2,864 |
| Neuropace, Inc. | 12 | $1,670 |
| UCB, Inc. | 57 | $1,420 |
| Jazz Pharmaceuticals Inc. | 19 | $1,298 |
| SK Life Science, Inc. | 36 | $1,044 |
| Biocodex, Inc. | 10 | $485 |
| Neurelis, Inc. | 24 | $385 |
| Upsher-smith Laboratories LLC | 12 | $379 |
| Acadia Pharmaceuticals Inc | 12 | $296 |
| Corium, LLC | 11 | $258 |
| Otter Pharmaceuticals, LLC | 9 | $252 |
| Aucta Pharmaceuticals, Inc. | 16 | $183 |
| Vertical Pharmaceuticals, LLC | 5 | $141 |
| Ironshore Pharmaceuticals Inc. | 7 | $110 |
| Pyros Pharmaceuticals, Inc. | 4 | $102 |
| Aquestive Therapeutics, Inc. | 4 | $93 |
| Tris Pharma Inc | 4 | $86 |
| Biogen | 3 | $85 |
| Supernus Pharmaceuticals, Inc. | 3 | $59 |
| Catalyst Pharmaceuticals, Inc. | 3 | $59 |
| Avion Pharmaceuticals | 2 | $58 |
| Springworks Therapeutics, Inc. | 2 | $53 |
| Noven Therapeutics, LLC | 2 | $45 |
| Amgen | 2 | $40 |
| Johnson & Johnson | 1 | $35 |
| Azurity Pharmaceuticals, Inc. | 1 | $34 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Immedica Pharma US, Inc. | 1 | $29 |
| ITF Therapeutics LLC | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| AstraZeneca | 1 | $22 |
| Octapharma USA, Inc. | 1 | $19 |
| Neos Therapeutics, LP | 1 | $16 |
| Sarepta Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RNS Neurostimulator Kit$1,498
- VNS Therapy$1,375
- Epidiolex$786
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$351
- DIACOMIT$246
- Fintepla$137
How this compares
$11,746 in reported general payments places this provider in the 85th percentile of 36 epilepsy providers in Texas.
Other epilepsy in Austin
- Karen KeoughAustin$474K
- Katherine LabinerAustin$163K
- Andrew LinAustin$42
- Jay HarveyDallas$19K
- Charles SzaboSan Antonio$15K
- Erin FiedlerDallas$9K
- Linda LearySan Antonio$9K
- Leonel EstofanEdinburg$9K
- Bernhard SuterHouston$6K
- Irfan AliHouston$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.